Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
LAKE SUCCESS, N.Y., April 10, 2015 (GLOBE NEWSWIRE) -- Flushing Financial Corporation (the "Company") (Nasdaq:FFIC), the parent holding company for Flushing Bank (the "Bank"), announced that the Bank...
-
DOYLESTOWN, Pa., April 10, 2015 (GLOBE NEWSWIRE) -- Anthony & Sylvan Pools has earned the coveted Angie's List Super Service Award – reflecting an exemplary year of service –...
-
WASHINGTON, April 10, 2015 (GLOBE NEWSWIRE) -- Last month, the American Fuel & Petrochemical Manufacturers (AFPM) and the American Petroleum Institute (API) filed a lawsuit in the U.S. District Court...
-
LOS ANGELES, April 10, 2015 (GLOBE NEWSWIRE) -- The basic concept behind Diet Doc's medical weight loss program is simple – train the body to rely on stored fat for fuel. By reducing...
-
DALLAS, April 10, 2015 (GLOBE NEWSWIRE) -- Cambium Learning® Group, Inc. (Nasdaq:ABCD), the educational solutions and services company that leverages engaging, innovative technology to help all...
-
ARMONK, N.Y., April 10, 2015 (GLOBE NEWSWIRE) -- IBM today announced at NAB2015 that Aspera, an IBM company, is unveiling the next generation of its unique FASP software platform for moving Big Data...
-
CALGARY, Alberta, April 10, 2015 (GLOBE NEWSWIRE) -- C-Era Property Management & Realty an Associa company, received the Branch of the Year award at Associa's 2015 Leadership Summit in Dallas. The...
-
LISLE, Ill., April 10, 2015 (GLOBE NEWSWIRE) -- Midwest Real Estate Data (MRED), Chicagoland's multiple listing service (MLS), has introduced functionality to its customers that allows Brokerages to...
-
SILVER SPRING, Md., April 10, 2015 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes...
-
SALT LAKE CITY, April 10, 2015 (GLOBE NEWSWIRE) -- Lipocine Inc.(Nasdaq:LPCN), a specialty pharmaceutical company, today announced that additional data from its ongoing Study of Oral Androgen...